Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Caitlin M. Wilmot

ID: 1b83c154-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

A Heightened Bar: Federal Circuit Leaves Functional Antibody Claims on Thin Ice

Biosimilars Law Bulletin · February 24, 2021

Amgen Faces “Uphill Battle” in Defending Antibody Genus Patentability

Biosimilars Law Bulletin · February 11, 2021

Big Pharma to Face Off at Federal Circuit Oral Arguments Over Antibody Genus Patentability

Biosimilars Law Bulletin · November 24, 2020

Federal Circuit Refuses to Reconsider Its Panel Decision Finding No Common Ownership of Immunex’s Enbrel Patents

Biosimilars Law Bulletin · October 6, 2020

Eli Lilly Files PGR Petition against Genentech’s IL-17A/F Heterodimer Patent

Biosimilars Law Bulletin · April 17, 2019

Previous

12...5

Next

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2016

Total Articles 22

Most Recent February 24, 2021

Cite This Author

Caitlin M. Wilmot, Rothwell Figg

LexBlog Author ID:

1b83c154-2619-30fb-68c4

www.lexblog.com/author/caitlinmwilmot

Contact

FirmRothwell Figg

Emailcwilmot@rothwellfigg.com

BlogsBiosimilars Law Bulletin

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog